| June Shannon Nease, RN | |
|
115 Rockwood Ln, Hazard, KY 41701-9415 | |
| (606) 436-5761 | |
| (606) 436-5797 |
| Full Name | June Shannon Nease |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Community Health |
| Location | 115 Rockwood Ln, Hazard, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063848463 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WA2000X | Registered Nurse - Administrator | 1072563 (Kentucky) | Secondary |
| 163WC1500X | Registered Nurse - Community Health | 1072563 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| June Shannon Nease, RN 115 Rockwood Ln, Hazard, KY 41701-9415 Ph: (606) 436-5761 | June Shannon Nease, RN 115 Rockwood Ln, Hazard, KY 41701-9415 Ph: (606) 436-5761 |
News Archive
CBSET, a non-for-profit preclinical research institute dedicated to biomedical research, education and advancement of medical technologies, announced today that its scientists have published data and analyses ("Fracture in drug-eluting stents increases focal intimal hyperplasia in the atherosclerosed rabbit iliac artery") that "illustrate differences in the dynamic healing responses to fractured and intact stent implanted in healthy and disease rabbit models."
"Investments in vaccines are one of the best and most cost-effective life-saving investments for the world's children, which is why we've made tough choices and trade-offs within our current global health portfolio to make this commitment"
Today, Pharmacyclics LLC, an AbbVie company, announced that ibrutinib (IMBRUVICA) improved progression-free survival (PFS; primary endpoint) and multiple secondary endpoints including overall survival (OS) and overall response rate (ORR) in treatment-naïve patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL, respectively) in the final analysis of the Phase III RESONATE™-2 (PCYC-1115) trial.
Leuphana University Lueneburg will apply for an EU Innovation Project, with an investment volume of up to EUR 1.6 billion - Big Data revolution in Healthcare through focused European collaboration in the most promising application areas - Strong partnerships with the University Medical Center Goettingen and the University of Zurich as well as the Republic of Malta, Sclavo Vaccines Association of Italy and ICHOM, among others.
› Verified 9 days ago
Ms. Nancy R Helton, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 210 Black Gold Blvd, Ste 107, Hazard, KY 41701 Phone: 606-436-2350 Fax: 606-436-2336 | |
Mable Wetmore, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 115 Rockwood Ln, Hazard, KY 41701 Phone: 606-436-5761 | |
Anna Herald, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 115 Rockwood Ln, Hazard, KY 41701 Phone: 606-436-5761 Fax: 606-436-5797 | |
Margaret Ann Triplett, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 115 Rockwood Ln, Hazard, KY 41701 Phone: 606-436-5761 Fax: 606-436-5797 | |
Kristen Rae Fugate, RN Registered Nurse Medicare: Medicare Enrolled Practice Location: 101 Airport Gardens Rd Ste 200, Hazard, KY 41701 Phone: 606-629-3121 | |
Sidney Baker, ARNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 441 Gorman Hollow Rd, Hazard, KY 41701 Phone: 606-439-2361 Fax: 606-439-0870 |